Vyome Holdings, Inc. ( HIND) - Key Metrics
HIND Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.10 | -$0.95 | -$0.95 |
| 2026Q1 | $0.01 | -$0.16 | -$0.24 | -$0.24 |
| 2025Q4 | $0.01 | -$0.21 | -$0.25 | -$0.25 |
| 2025Q3 | $0.12 | -$28.86 | $14.86 | $14.86 |
| 2025Q2 | $4.25 | -$9 | -$15.38 | -$15.38 |
HIND Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.37 |
| 2026Q1 | 0% | -3.16 |
| 2025Q4 | 0% | -4.10 |
| 2025Q3 | 0% | -0.04 |
| 2025Q2 | 0% | -0.27 |
HIND
Price: $2.25
52 week price:
Earnings Per Share: -1.61 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 15.9 million